小方制药
(603207)
| 流通市值：12.38亿 | | | 总市值：36.68亿 |
| 流通股本：5460.29万 | | | 总股本：1.62亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 425,897,267.01 | 281,930,889.08 | 145,694,452.27 | 525,280,851.39 |
| 营业总成本 | 248,480,044.91 | 159,156,289.08 | 80,034,518.55 | 283,033,965.67 |
| 其他经营收益 | | | | |
| 营业利润 | 179,153,411.17 | 123,583,674.49 | 65,587,371.39 | 241,519,793.7 |
| 利润总额 | 180,377,718.72 | 123,463,674.57 | 65,462,789.19 | 241,227,209.98 |
| 净利润 | 155,552,736.34 | 105,550,017.8 | 56,006,923.51 | 207,489,677.18 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 155,552,736.34 | 105,550,017.8 | 56,006,923.51 | 207,489,677.18 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 901,833,366.41 | 905,205,501.12 | 882,917,988.24 | 859,857,709.31 |
| 非流动资产: | | | | |
| 非流动资产合计 | 404,692,626.5 | 401,449,031.62 | 378,488,933.63 | 379,613,739.86 |
| 资产总计 | 1,306,525,992.91 | 1,306,654,532.74 | 1,261,406,921.87 | 1,239,471,449.17 |
| 流动负债: | | | | |
| 流动负债合计 | 173,590,159.25 | 163,180,690.09 | 110,787,007.23 | 146,340,087.77 |
| 非流动负债: | | | | |
| 非流动负债合计 | 42,857.04 | 150,298.27 | 89,477.69 | 371,360.38 |
| 负债合计 | 173,633,016.29 | 163,330,988.36 | 110,876,484.92 | 146,711,448.15 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,132,892,976.62 | 1,143,323,544.38 | 1,150,530,436.95 | 1,092,760,001.02 |
| 股东权益合计 | 1,132,892,976.62 | 1,143,323,544.38 | 1,150,530,436.95 | 1,092,760,001.02 |
| 负债和股东权益合计 | 1,306,525,992.91 | 1,306,654,532.74 | 1,261,406,921.87 | 1,239,471,449.17 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 494,262,848.64 | 314,794,135.84 | 154,822,126.7 | 566,040,805.13 |
| 经营活动现金流出小计 | 322,255,947.77 | 217,058,859.01 | 109,490,900.1 | 405,244,155.65 |
| 经营活动产生的现金流量净额 | 172,006,900.87 | 97,735,276.83 | 45,331,226.6 | 160,796,649.48 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 424,644,597.02 | 149,281,500 | 4,730,208.33 | 927,249,283.35 |
| 投资活动现金流出小计 | 732,881,467.96 | 385,764,231.19 | 359,097,176.78 | 621,240,215.64 |
| 投资活动产生的现金流量净额 | -308,236,870.94 | -236,482,731.19 | -354,366,968.45 | 306,009,067.71 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 28,712,180.74 | 9,109,533.75 | 9,674,978.61 | 9,501,775.57 |
| 筹资活动现金流出小计 | 62,375,864.48 | 20,016,031.12 | 40,500 | 358,967,747.4 |
| 筹资活动产生的现金流量净额 | -33,663,683.74 | -10,906,497.37 | 9,634,478.61 | -349,465,971.83 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -169,893,653.81 | -149,653,951.73 | -299,401,263.24 | 117,339,745.36 |
| 期末现金及现金等价物余额 | 374,295,942.54 | 394,535,644.62 | 244,788,333.11 | 544,189,596.35 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -149,653,951.73 | - | 117,339,745.36 |